Clarus Defined Exit I, L.P. - Insider Trading & Ownership

Entity
Company
Location
101 Main Street, Suite 1210, Cambridge, MA
Summary
The estimated value of insider holdings of Clarus Defined Exit I, L.P. is at least $2.72M dollars as of May 13, 2021. Clarus Defined Exit I, L.P. is the 10%+ Owner of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $2.72M.
All Insider Reports
All Insider Reports

Ownership of Clarus Defined Exit I, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRML Tourmaline Bio, Inc. 10%+ Owner $2.72M May 11, 2021

Insider Transactions Reported by Clarus Defined Exit I, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.